FDA Targets Makers Of OTC COVID-19 Tests With Tweaks To 2 EUA Templates
Executive Summary
The US agency made changes to two of its emergency use authorization templates “to support authorization of more COVID-19 tests” for over-the-counter use and to offer “flexible study recommendations.”